Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and

Alexey Moskalev1,2,3,4, Elizaveta Chernyagina2, João Pedro de Magalhães5,6

  • 1Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of Russian Academy of Sciences, Syktyvkar 167982, Russia.

Aging
|September 7, 2015
PubMed

Insights

Researchers have developed Geroprotectors, a new database cataloging over 200 compounds that extend lifespan. This resource aids aging research by compiling geroprotector effects and linking to vital studies and databases.

Area of Science:

  • Gerontology
  • Biochemistry
  • Pharmacology

Background:

  • Growing interest in aging research necessitates a centralized resource for geroprotectors.
  • Existing research lacks a manually curated database for geroprotector effects and related data.
  • Therapeutic interventions, or geroprotectors, aim to extend healthy lifespan and mitigate aging-related damage.

Purpose of the Study:

  • To introduce Geroprotectors, the first manually curated database of geroprotectors.
  • To compile and index the effects of geroprotectors on aging and age-related diseases.
  • To link geroprotector data to relevant studies and biochemical/drug databases.

Main Methods:

  • Developed a public, explorable online database (http://geroprotectors.org).
  • Cataloged over 250 experiments involving more than 200 geroprotectors.
  • Included comprehensive profiles for each compound: biochemistry, mechanisms, lifespan effects, chemical structure, side effects, toxicity, and FDA drug status.

Main Results:

  • The Geroprotectors database contains over 200 known or candidate geroprotectors.
  • Each compound profile links to source studies and databases for data validation.
  • The database provides a visually intuitive framework for browsing and research.

Conclusions:

  • Geroprotectors serves as a valuable, time-saving resource for researchers in aging.
  • Facilitates cross-study, cross-organism, and cross-discipline analysis.
  • Aids in the discovery of healthy aging solutions through comprehensive data aggregation.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
357
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
324
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
344
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
813
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
326